<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://hmg.oxfordjournals.org">
<title>Human Molecular Genetics - current issue</title>
<link>http://hmg.oxfordjournals.org</link>
<description>Human Molecular Genetics - RSS feed of current issue</description>
<prism:eIssn>1460-2083</prism:eIssn>
<prism:coverDisplayDate>15 December 2009</prism:coverDisplayDate>
<prism:publicationName>Human Molecular Genetics</prism:publicationName>
<prism:issn>0964-6906</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-a?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-b?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-c?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4689?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4699?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4711?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4724?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4734?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4746?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4756?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4770?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4781?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4791?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4801?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4808?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4818?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4830?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4843?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4853?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4868?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4879?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4897?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4905?rss=1" />
  <rdf:li rdf:resource="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4907?rss=1" />
 </rdf:Seq>
</items>
</channel>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP?rss=1">
<title><![CDATA[Contents Page]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp491</dc:identifier>
<dc:title><![CDATA[Contents Page]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>NP</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>NP</prism:startingPage>
<prism:section>FRONT-MATTER/BACK-MATTER</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-a?rss=1">
<title><![CDATA[Cover Page]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-a?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp492</dc:identifier>
<dc:title><![CDATA[Cover Page]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>NP</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>NP</prism:startingPage>
<prism:section>FRONT-MATTER/BACK-MATTER</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-b?rss=1">
<title><![CDATA[Editorial Board]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-b?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp493</dc:identifier>
<dc:title><![CDATA[Editorial Board]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>NP</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>NP</prism:startingPage>
<prism:section>FRONT-MATTER/BACK-MATTER</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-c?rss=1">
<title><![CDATA[Subscription Page]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/NP-c?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp494</dc:identifier>
<dc:title><![CDATA[Subscription Page]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>NP</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>NP</prism:startingPage>
<prism:section>FRONT-MATTER/BACK-MATTER</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4689?rss=1">
<title><![CDATA[The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4689?rss=1</link>
<description><![CDATA[
<p>Mitochondria are organelles of all nucleated cells, and variations in mtDNA sequence affect a wide spectrum of human diseases. However, animal models for mtDNA-associated diseases are rare, making it challenging to explore mechanisms underlying the contribution of mitochondria. Here, we identify a polymorphism in the mitochondrial genome, G-to-T at position 7778, which results in an aspartic acid-to-tyrosine (D-Y) substitution in the fifth amino acid of the highly conserved N-terminus of ATP synthase 8 (<I>ATP8</I>). Using a series of conplastic strains we show that this polymorphism increases susceptibility to multiple autoimmune diseases, including collagen-induced arthritis, autoimmune diabetes, nephritis and autoimmune pancreatitis. In addition, it impairs reproductive performance in females, but only in the MRL/MpJ strain. We also demonstrate that the <I>mtAtp8</I> polymorphism alters mitochondrial performance, increasing H<SUB>2</SUB>O<SUB>2</SUB> production and affecting mitochondrial structure. Functional analysis reveals that the polymorphism increase the CD4 T cell adaptive potential to an oxidative phosphorylation impaired condition. Our findings provide direct experimental evidence for the role of mitochondria in autoimmunity and reproduction.</p>
]]></description>
<dc:creator><![CDATA[Yu, X., Wester-Rosenlof, L., Gimsa, U., Holzhueter, S.-A., Marques, A., Jonas, L., Hagenow, K., Kunz, M., Nizze, H., Tiedge, M., Holmdahl, R., Ibrahim, S. M.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp432</dc:identifier>
<dc:title><![CDATA[The mtDNA nt7778 G/T polymorphism affects autoimmune diseases and reproductive performance in the mouse]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4698</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4689</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4699?rss=1">
<title><![CDATA[AIRE activated tissue specific genes have histone modifications associated with inactive chromatin]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4699?rss=1</link>
<description><![CDATA[
<p>The Autoimmune Regulator (AIRE) protein is expressed in thymic medullary epithelial cells, where it promotes the ectopic expression of tissue-restricted antigens needed for efficient negative selection of developing thymocytes. Mutations in AIRE cause APECED syndrome, which is characterized by a breakdown of self-tolerance. The molecular mechanism by which AIRE increases the expression of a variety of different genes remains unknown. Here, we studied AIRE-regulated genes using whole genome expression analysis and chromatin immunoprecipitation. We show that AIRE preferentially activates genes that are tissue-specific and characterized by low levels of initial expression in stably transfected HEK293 cell model and mouse thymic medullary epithelial cells. In addition, the AIRE-regulated genes lack active chromatin marks, such as histone H3 trimethylation (H3K4me3) and acetylation (AcH3), on their promoters. We also show that during activation by AIRE, the target genes acquire histone H3 modifications associated with transcription and RNA polymerase II. In conclusion, our data show that AIRE is able to promote ectopic gene expression from chromatin associated with histone modifications characteristic to inactive genes.</p>
]]></description>
<dc:creator><![CDATA[Org, T., Rebane, A., Kisand, K., Laan, M., Haljasorg, U., Andreson, R., Peterson, P.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp433</dc:identifier>
<dc:title><![CDATA[AIRE activated tissue specific genes have histone modifications associated with inactive chromatin]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4710</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4699</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4711?rss=1">
<title><![CDATA[Nephrocystin-1 and nephrocystin-4 are required for epithelial morphogenesis and associate with PALS1/PATJ and Par6]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4711?rss=1</link>
<description><![CDATA[
<p>Nephronophthisis (NPH) is an autosomal recessive disorder characterized by renal fibrosis, tubular basement membrane disruption and corticomedullary cyst formation leading to end-stage renal failure. The disease is caused by mutations in <I>NPHP1-9</I> genes, which encode the nephrocystins, proteins localized to cell&ndash;cell junctions and centrosome/primary cilia. Here, we show that nephrocystin mRNA expression is dramatically increased during cell polarization, and shRNA-mediated knockdown of either <I>NPHP1</I> or <I>NPHP4</I> in MDCK cells resulted in delayed tight junction (TJ) formation, abnormal cilia formation and disorganized multi-lumen structures when grown in a three-dimensional collagen matrix. Some of these phenotypes are similar to those reported for cells depleted of the TJ proteins PALS1 or Par3, and interestingly, we demonstrate a physical interaction between these nephrocystins and PALS1 as well as their partners PATJ and Par6 and show their partial co-localization in human renal tubules. Taken together, these results demonstrate that the nephrocystins play an essential role in epithelial cell organization, suggesting a plausible mechanism by which the <I>in vivo</I> histopathologic features of NPH might develop.</p>
]]></description>
<dc:creator><![CDATA[Delous, M., Hellman, N. E., Gaude, H.-M., Silbermann, F., Le Bivic, A., Salomon, R., Antignac, C., Saunier, S.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp434</dc:identifier>
<dc:title><![CDATA[Nephrocystin-1 and nephrocystin-4 are required for epithelial morphogenesis and associate with PALS1/PATJ and Par6]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4723</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4711</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4724?rss=1">
<title><![CDATA[Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4724?rss=1</link>
<description><![CDATA[
<p>Genomic imprinting plays an important role in mammalian development. Loss of imprinting (LOI) through loss (LOM) or gain (GOM) of methylation is involved in many human disorders and cancers. The imprinted 11p15 region is crucial for the control of foetal growth and LOI at this locus is implicated in two clinically opposite disorders: Beckwith Wiedemann syndrome (BWS) with foetal overgrowth associated with an enhanced tumour risk and Russell&ndash;Silver syndrome (RSS) with intrauterine and postnatal growth restriction. So far, only a few studies have assessed multilocus LOM in human imprinting diseases. To investigate multilocus LOI syndrome, we studied the methylation status of five maternally and two paternally methylated loci in a large series (<I>n</I> = 167) of patients with 11p15-related foetal growth disorders. We found that 9.5% of RSS and 24% of BWS patients showed multilocus LOM at regions other than ICR1 and ICR2 11p15, respectively. Moreover, over two third of multilocus LOM RSS patients also had LOM at a second paternally methylated locus, <I>DLK1/GTL2</I> IG-DMR. No additional clinical features due to LOM of other loci were found suggesting an (epi)dominant effect of the 11p15 LOM on the clinical phenotype for this series of patients. Surprisingly, four patients displayed LOM at both ICR1 and ICR2 11p15. Three of them had a RSS and one a BWS phenotype. Our results show for the first time that multilocus LOM can also concern RSS patients. Moreover, LOM can involve both paternally and maternally methylated loci in the same patient.</p>
]]></description>
<dc:creator><![CDATA[Azzi, S., Rossignol, S., Steunou, V., Sas, T., Thibaud, N., Danton, F., Le Jule, M., Heinrichs, C., Cabrol, S., Gicquel, C., Le Bouc, Y., Netchine, I.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp435</dc:identifier>
<dc:title><![CDATA[Multilocus methylation analysis in a large cohort of 11p15-related foetal growth disorders (Russell Silver and Beckwith Wiedemann syndromes) reveals simultaneous loss of methylation at paternal and maternal imprinted loci]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4733</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4724</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4734?rss=1">
<title><![CDATA[EKV mutant connexin 31 associated cell death is mediated by ER stress]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4734?rss=1</link>
<description><![CDATA[
<p>The epidermis expresses a number of connexin (Cx) proteins that are implicated in gap junction-mediated cell communication. Distinct dominantly inherited mutations in Cx31 cause the skin disease erythrokeratoderma variabilis (EKV) and hearing loss with or without neuropathy. Functional studies reveal tissue-specific effects of these Cx31 disease-associated mutations. The Cx31 mutants (R42P)Cx31, (C86S)Cx31 and (G12D)Cx31 are associated with EKV and the mutant (66delD)Cx31 with peripheral neuropathy and hearing loss, however the mechanisms of pathogenesis remain to be elucidated. Expression of (R42P)Cx31, (C86S)Cx31 and (G12D)Cx31 <I>in vitro</I>, but not (WT)Cx31 or (66delD)Cx31, cause elevated levels of cell-type specific cell death. Previous studies suggest that Cx-associated cell death may be related to abnormal &lsquo;leaky&rsquo; hemichannels but we produced direct evidence against that being the major mechanism. Additionally, our immunocytochemistry showed upregulation of components of the unfolded protein response (UPR) in cells expressing the EKV-associated Cx31 mutants but not (WT)Cx31 or (66delD)Cx31. We conclude that the endoplasmic reticulum (ER) stress leading to the UPR is the main mechanism of mutant Cx31-associated cell death. These results indicate that, <I>in vivo</I>, ER stress may lead to abnormal keratinocyte differentiation and hyperproliferation in EKV patient skin.</p>
]]></description>
<dc:creator><![CDATA[Tattersall, D., Scott, C. A., Gray, C., Zicha, D., Kelsell, D. P.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp436</dc:identifier>
<dc:title><![CDATA[EKV mutant connexin 31 associated cell death is mediated by ER stress]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4745</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4734</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4746?rss=1">
<title><![CDATA[Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4746?rss=1</link>
<description><![CDATA[
<p>Mutations in the MEditerranean FeVer (<I>MEFV</I>) gene are responsible for familial Mediterranean fever (FMF), a recessively inherited auto-inflammatory disease. Cases of dominant inheritance and phenotype&ndash;genotype heterogeneity have been reported; however, the underlying molecular mechanism is not currently understood. The FMF protein named pyrin or marenostrin (P/M) is thought to be involved in regulating innate immunity but its function remains subject to controversy. Recent studies postulate that a defect in <I>MEFV</I> expression regulation may play a role in FMF physiopathology. Our group, along with others, has identified several alternatively spliced <I>MEFV</I> transcripts in leukocytes. Since alternative splicing and nonsense-mediated decay (NMD) pathways are usually coupled in the post-transcriptional regulation of gene expression, we hypothesized that NMD could contribute to the regulation of the <I>MEFV</I> gene. To address this issue, we examined the effect of indirect and direct inhibition of NMD on expression of the <I>MEFV</I> transcripts in THP1, monocyte and neutrophil cells. We showed that <I>MEFV</I> is the first auto-inflammatory gene regulated by NMD in both a cell- and transcript-specific manner. These results and preliminary western-blot analyses suggest the possible translation of alternatively spliced <I>MEFV</I> transcripts into several P/M variants according to cell type and inflammatory state. Our results introduce the novel hypothesis that variation of NMD efficiency could play an important role in FMF physiopathology as a potent phenotypic modifier.</p>
]]></description>
<dc:creator><![CDATA[Grandemange, S., Soler, S., Touitou, I.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp437</dc:identifier>
<dc:title><![CDATA[Expression of the familial Mediterranean fever gene is regulated by nonsense-mediated decay]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4755</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4746</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4756?rss=1">
<title><![CDATA[A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4756?rss=1</link>
<description><![CDATA[
<p>Mental retardation in Down syndrome (DS), the most frequent trisomy in humans, varies from moderate to severe. Several studies both in human and based on mouse models identified some regions of human chromosome 21 (Hsa21) as linked to cognitive deficits. However, other intervals such as the telomeric region of Hsa21 may contribute to the DS phenotype but their role has not yet been investigated in detail. Here we show that the trisomy of the 12 genes, found in the 0.59 Mb <I>(Abcg1&ndash;U2af1)</I> Hsa21 sub-telomeric region, in mice (Ts1Yah) produced defects in novel object recognition, open-field and Y-maze tests, similar to other DS models, but induces an improvement of the hippocampal-dependent spatial memory in the Morris water maze along with enhanced and longer lasting long-term potentiation <I>in vivo</I> in the hippocampus. Overall, we demonstrate the contribution of the <I>Abcg1&ndash;U2af1</I> genetic region to cognitive defect in working and short-term recognition memory in DS models. Increase in copy number of the <I>Abcg1&ndash;U2af1</I> interval leads to an unexpected gain of cognitive function in spatial learning. Expression analysis pinpoints several genes, such as <I>Ndufv3</I>, <I>Wdr4</I>, <I>Pknox1</I> and <I>Cbs</I>, as candidates whose overexpression in the hippocampus might facilitate learning and memory in Ts1Yah mice. Our work unravels the complexity of combinatorial genetic code modulating different aspect of mental retardation in DS patients. It establishes definitely the contribution of the <I>Abcg1&ndash;U2af1</I> orthologous region to the DS etiology and suggests new modulatory pathways for learning and memory.</p>
]]></description>
<dc:creator><![CDATA[Pereira, P. L., Magnol, L., Sahun, I., Brault, V., Duchon, A., Prandini, P., Gruart, A., Bizot, J.-C., Chadefaux-Vekemans, B., Deutsch, S., Trovero, F., Delgado-Garcia, J. M., Antonarakis, S. E., Dierssen, M., Herault, Y.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp438</dc:identifier>
<dc:title><![CDATA[A new mouse model for the trisomy of the Abcg1-U2af1 region reveals the complexity of the combinatorial genetic code of down syndrome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4769</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4756</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4770?rss=1">
<title><![CDATA[Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4770?rss=1</link>
<description><![CDATA[
<p>The cone cyclic nucleotide-gated (CNG) channel is essential for central and color vision and visual acuity. This channel is composed of two structurally related subunits, CNGA3 and CNGB3; CNGA3 is the ion-conducting subunit, whereas CNGB3 is a modulatory subunit. Mutations in both subunits are associated with achromatopsia and progressive cone dystrophy, with mutations in <I>CNGB3</I> alone accounting for 50% of all known cases of achromatopsia. However, the molecular mechanisms underlying cone diseases that result from CNGB3 deficiency are unknown. This study investigated the role of CNGB3 in cones, using <I>CNGB3</I><sup><I>&ndash;/&ndash;</I></sup> mice. Cone dysfunction was apparent at the earliest time point examined (post-natal day 30) in <I>CNGB3</I><sup><I>&ndash;/&ndash;</I></sup> mice. When compared with wild-type (WT) controls: photopic electroretingraphic (ERG) responses were decreased by ~75%, whereas scotopic ERG responses were unchanged; visual acuity was decreased by ~20%, whereas contrast sensitivity was unchanged; cone density was reduced by ~40%; photoreceptor apoptosis was detected; and outer segment disorganization was observed in some cones. Notably, CNGA3 protein and mRNA levels were significantly decreased in <I>CNGB3</I><sup><I>&ndash;/&ndash;</I></sup> mice; in contrast, mRNA levels of S-opsin, Gnat2 and Pde6c were unchanged, relative to WT mice. Hence, we show that loss of CNGB3 reduces biosynthesis of CNGA3 and impairs cone CNG channel function. We suggest that down-regulation of CNGA3 contributes to the pathogenic mechanism by which CNGB3 mutations lead to human cone disease.</p>
]]></description>
<dc:creator><![CDATA[Ding, X.-Q., Harry, C. S., Umino, Y., Matveev, A. V., Fliesler, S. J., Barlow, R. B.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp440</dc:identifier>
<dc:title><![CDATA[Impaired cone function and cone degeneration resulting from CNGB3 deficiency: down-regulation of CNGA3 biosynthesis as a potential mechanism]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4780</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4770</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4781?rss=1">
<title><![CDATA[Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4781?rss=1</link>
<description><![CDATA[
<p>Hepatocellular adenoma (HCA) is a frequent long-term complication of glycogen storage disease type I (GSD I) and malignant transformation to hepatocellular carcinoma (HCC) is known to occur in some cases. However, the molecular pathogenesis of tumor development in GSD I is unclear. This study was conducted to systematically investigate chromosomal and genetic alterations in HCA associated with GSD I. Genome-wide SNP analysis and mutation detection of target genes was performed in ten GSD Ia-associated HCA and seven general population HCA cases for comparison. Chromosomal aberrations were detected in 60% of the GSD Ia HCA and 57% of general population HCA. Intriguingly, simultaneous gain of chromosome 6p and loss of 6q were only seen in GSD Ia HCA (three cases) with one additional GSD I patient showing submicroscopic 6q14.1 deletion. The sizes of GSD Ia adenomas with chromosome 6 aberrations were larger than the sizes of adenomas without the changes (<I>P</I> = 0.012). Expression of IGF2R and LATS1 candidate tumor suppressor genes at 6q was reduced in more than 50% of GSD Ia HCA that were examined (<I>n</I> = 7). None of the GSD Ia HCA had biallelic mutations in the HNF1A gene. These findings give the first insight into the distinct genomic and genetic characteristics of HCA associated with GSD Ia. These results strongly suggest that chromosome 6 alterations could be an early event in the liver tumorigenesis in GSD I, and may be in general population. These results also suggest an interesting relationship between GSD Ia HCA and steps to HCC transformation.</p>
]]></description>
<dc:creator><![CDATA[Kishnani, P. S., Chuang, T.-P., Bali, D., Koeberl, D., Austin, S., Weinstein, D. A., Murphy, E., Chen, Y.-T., Boyette, K., Liu, C.-H., Chen, Y.-T., Li, L.-H.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp441</dc:identifier>
<dc:title><![CDATA[Chromosomal and genetic alterations in human hepatocellular adenomas associated with type Ia glycogen storage disease]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4790</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4781</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4791?rss=1">
<title><![CDATA[Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4791?rss=1</link>
<description><![CDATA[
<p>Filamin A (FLNA) crosslinks F-actin and binds proteins consistent with roles integrating cell signalling and the cytoskeleton. FLNA missense mutations are associated with the otopalatodigital syndrome (OPD) spectrum of skeletal disorders, clustering in discrete domains. One cluster is found in the second calponin homology domain of the FLNA actin-binding domain (ABD), implicating this region as essential for mediating correct function. Here we show that OPD (FLNA E254K) fibroblast lysates have equivalent concentrations of FLNA compared with controls and that recombinant FLNA E254K ABD has increased <I>in vitro</I> F-actin binding (<I>K</I><SUB>d</SUB> 13 &micro;<scp>m</scp>) compared with wild type (WT; <I>K</I><SUB>d</SUB> 48 &micro;<scp>m</scp>). These observations are consistent with a gain-of-function mechanism for OPD. We have determined the crystal structures of the WT and E254K FLNA ABDs at 2.3 &Aring; resolution, revealing that they adopt similar closed conformations. The E254K mutation removes a conserved salt bridge but does not disrupt the ABD structure. The solution structures are also equivalent as determined by circular dichroism spectroscopy, but differential scanning fluorimetry denaturation showed reduced stability (decreased <I>T</I><SUB>m</SUB> of 5.6&deg;C) for E254K relative to WT. <I>Ex vivo</I> characterization of E254K OPD patient fibroblasts revealed they have similar motility and adhesion as control cells, implying that many core functions mediated by FLNA are unaffected, consistent with OPD only affecting specific tissues despite FLNA being widely expressed. These data provide the first biochemical evidence for a gain-of-function mechanism for the OPD disorders, and mechanistically distinguishes them from the loss-of-function phenotypes that manifest as disorders of neuronal migration.</p>
]]></description>
<dc:creator><![CDATA[Clark, A. R., Sawyer, G. M., Robertson, S. P., Sutherland-Smith, A. J.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp442</dc:identifier>
<dc:title><![CDATA[Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4800</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4791</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4801?rss=1">
<title><![CDATA[Adenosine deamination in human transcripts generates novel microRNA binding sites]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4801?rss=1</link>
<description><![CDATA[
<p>Animals regulate gene expression at multiple levels, contributing to the complexity of the proteome. Among these regulatory events are post-transcriptional gene silencing, mediated by small non-coding RNAs (e.g. microRNAs), and adenosine-to-inosine (A-to-I) editing, generated by adenosine deaminases that act on double-stranded RNA (ADAR). Recent data suggest that these regulatory processes are connected at a fundamental level. A-to-I editing can affect Drosha processing or directly alter the microRNA (miRNA) sequences responsible for mRNA targeting. Here, we analyzed the previously reported adenosine deaminations occurring in human cDNAs, and asked if there was a relationship between A-to-I editing events in the mRNA 3' untranslated regions (UTRs) and mRNA:miRNA binding. We find significant correlations between A-to-I editing and changes in miRNA complementarities. In all, over 3000 of the 12 723 distinct adenosine deaminations assessed were found to form 7-mer complementarities (known as seed matches) to a subset of human miRNAs. In 200 of the ESTs, we also noted editing within a specific 13 nucleotide motif. Strikingly, deamination of this motif simultaneously creates seed matches to three (otherwise unrelated) miRNAs. Our results suggest the creation of miRNA regulatory sites as a novel function for ADAR activity. Consequently, many miRNA target sites may only be identifiable through examining expressed sequences.</p>
]]></description>
<dc:creator><![CDATA[Borchert, G. M., Gilmore, B. L., Spengler, R. M., Xing, Y., Lanier, W., Bhattacharya, D., Davidson, B. L.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp443</dc:identifier>
<dc:title><![CDATA[Adenosine deamination in human transcripts generates novel microRNA binding sites]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4807</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4801</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4808?rss=1">
<title><![CDATA[Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4808?rss=1</link>
<description><![CDATA[
<p>DNA methylation is known to be associated with cell differentiation, aging, disease and cancer. There exists an expanding base of knowledge regarding tissue-specific DNA methylation, but we have little information about person-specific DNA methylation. Here, we analyze the DNA methylation patterns of multiple tissues from multiple individuals using a high-throughput quantitative assay of genome-wide DNA methylation, namely the Illumina GoldenGate BeadArray. DNA methylation patterns were largely conserved across 11 different tissues (<I>r</I> = 0.852) and across six individuals (<I>r</I> = 0.829), and we found that DNA was highly methylated in non-CpG islands and/or CpG sites that are not occupied by either H3K4me3 or H3K27me3 (<I>P</I> &lt; 0.05). Finally, we found that the Illumina GoldenGate assay features a large number of probes (265/1505 probes, 17.6%) that contain single-nucleotide polymorphisms, which may interfere with DNA methylation analyses in genome-wide studies.</p>
]]></description>
<dc:creator><![CDATA[Byun, H.-M., Siegmund, K. D., Pan, F., Weisenberger, D. J., Kanel, G., Laird, P. W., Yang, A. S.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp445</dc:identifier>
<dc:title><![CDATA[Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4817</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4808</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4818?rss=1">
<title><![CDATA[Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4818?rss=1</link>
<description><![CDATA[
<p>MicroRNAs (miRs) are non-coding RNA molecules involved in cancer initiation and progression. Deregulated miR expression has been implicated in cancer; however, there are no studies implicating an miR signature associated with progression in oral squamous cell carcinoma (OSCC). Although OSCC may develop from oral leukoplakia, clinical and histological assessments have limited prognostic value in predicting which leukoplakic lesions will progress. Our aim was to quantify miR expression changes in leukoplakia and same-site OSCC and to identify an miR signature associated with progression. We examined miR expression changes in 43 sequential progressive samples from 12 patients and four non-progressive leukoplakias from four different patients, using TaqMan Low Density Arrays. The findings were validated using quantitative RT-PCR in an independent cohort of 52 progressive dysplasias and OSCCs, and five non-progressive dysplasias. Global miR expression profiles distinguished progressive leukoplakia/OSCC from non-progressive leukoplakias/normal tissues. One hundred and nine miRs were highly expressed exclusively in progressive leukoplakia and invasive OSCC. miR-21, miR-181b and miR-345 expressions were consistently increased and associated with increases in lesion severity during progression. Over-expression of miR-21, miR-181b and miR-345 may play an important role in malignant transformation. Our study provides the first evidence of an miR signature potentially useful for identifying leukoplakias at risk of malignant transformation.</p>
]]></description>
<dc:creator><![CDATA[Cervigne, N. K., Reis, P. P., Machado, J., Sadikovic, B., Bradley, G., Galloni, N. N., Pintilie, M., Jurisica, I., Perez-Ordonez, B., Gilbert, R., Gullane, P., Irish, J., Kamel-Reid, S.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp446</dc:identifier>
<dc:title><![CDATA[Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4829</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4818</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4830?rss=1">
<title><![CDATA[Selective neuronal requirement for huntingtin in the developing zebrafish]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4830?rss=1</link>
<description><![CDATA[
<p>Huntington's disease shares a common molecular basis with eight other neurodegenerative diseases, expansion of an existing polyglutamine tract. In each case, this repeat tract occurs within otherwise unrelated proteins. These proteins show widespread and overlapping patterns of expression in the brain and yet the diseases are distinguished by neurodegeneration in a specific subset of neurons that are most sensitive to the mutation. It has therefore been proposed that expansion of the polyglutamine region in these genes may result in perturbation of the normal function of the respective proteins, and that this perturbation in some way contributes to the neuronal specificity of these diseases. The normal functions of these proteins have therefore become a focus for investigation as potential pathogenic pathways. We have used synthetic antisense morpholinos to inhibit the translation of huntingtin mRNA during early zebrafish development and have previously reported the effects of huntingtin reduction on iron transport and homeostasis. Here we report an analysis of the effects of huntingtin loss-of-function on the developing nervous system, observing distinct defects in morphology of neuromasts, olfactory placode and branchial arches. The potential common origins of these defects were explored, revealing impaired formation of the anterior-most region of the neural plate as indicated by reduced pre-placodal and telencephalic gene expression with no effect on mid- or hindbrain formation. These investigations demonstrate a specific &lsquo;rate-limiting&rsquo; role for huntingtin in formation of the telencephalon and the pre-placodal region, and differing levels of requirement for huntingtin function in specific nerve cell types.</p>
]]></description>
<dc:creator><![CDATA[Henshall, T. L., Tucker, B., Lumsden, A. L., Nornes, S., Lardelli, M. T., Richards, R. I.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp455</dc:identifier>
<dc:title><![CDATA[Selective neuronal requirement for huntingtin in the developing zebrafish]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4842</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4830</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4843?rss=1">
<title><![CDATA[Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4843?rss=1</link>
<description><![CDATA[
<p>Protein cleavage is a common feature in human neurodegenerative disease. Ataxin-3 protein with an expanded polyglutamine (polyQ) repeat causes spinocerebellar ataxia type-3 (SCA3), also called Machado&ndash;Joseph disease, and is cleaved in mammalian cells, transgenic mice and SCA3 patient brain tissue. However, the pathological significance of Ataxin-3 cleavage has not been carefully examined. To gain insight into the significance of Ataxin-3 cleavage, we developed a <I>Drosophila</I> SL2 cell-based model as well as transgenic fly models. Our data indicate that Ataxin-3 protein cleavage is conserved in the fly and may be caspase-dependent as reported previously. Importantly, comparison of flies expressing either wild-type or caspase-site mutant proteins indicates that Ataxin-3 cleavage enhances neuronal loss <I>in vivo</I>. This genetic <I>in vivo</I> confirmation of the pathological role of Ataxin-3 cleavage indicates that therapies targeting Ataxin-3 cleavage might slow disease progression in SCA3 patients.</p>
]]></description>
<dc:creator><![CDATA[Jung, J., Xu, K., Lessing, D., Bonini, N. M.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp456</dc:identifier>
<dc:title><![CDATA[Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4852</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4843</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4853?rss=1">
<title><![CDATA[Detecting natural selection by empirical comparison to random regions of the genome]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4853?rss=1</link>
<description><![CDATA[
<p>Historical episodes of natural selection can skew the frequencies of genetic variants, leaving a signature that can persist for many tens or even hundreds of thousands of years. However, formal tests for selection based on allele frequency skew require strong assumptions about demographic history and mutation, which are rarely well understood. Here, we develop an empirical approach to test for signals of selection that compares patterns of genetic variation at a candidate locus with matched random regions of the genome collected in the same way. We apply this approach to four genes that have been implicated in syndromes of impaired neurological development, comparing the pattern of variation in our re-sequencing data with a large-scale, genomic data set that provides an empirical null distribution. We confirm a previously reported signal at <I>FOXP2</I>, and find a novel signal of selection centered at <I>AHI1</I>, a gene that is involved in motor and behavior abnormalities. The locus is marked by many high frequency derived alleles in non-Africans that are of low frequency in Africans, suggesting that selection at this or a closely neighboring gene occurred in the ancestral population of non-Africans. Our study also provides a prototype for how empirical scans for ancient selection can be carried out once many genomes are sequenced.</p>
]]></description>
<dc:creator><![CDATA[Yu, F., Keinan, A., Chen, H., Ferland, R. J., Hill, R. S., Mignault, A. A., Walsh, C. A., Reich, D.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp457</dc:identifier>
<dc:title><![CDATA[Detecting natural selection by empirical comparison to random regions of the genome]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4867</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4853</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4868?rss=1">
<title><![CDATA[Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4868?rss=1</link>
<description><![CDATA[
<p>Mutations affecting the conversion of PI3P to the signaling lipid PI(3,5)P<SUB>2</SUB> result in spongiform degeneration of mouse brain and are associated with the human disorders Charcot&ndash;Marie&ndash;Tooth disease and amyotrophic lateral sclerosis (ALS). We now report accumulation of the proteins LC3-II, p62 and LAMP-2 in neurons and astrocytes of mice with mutations in two components of the PI(3,5)P<SUB>2</SUB> regulatory complex, <I>Fig4</I> and <I>Vac14</I>. Cytoplasmic inclusion bodies containing p62 and ubiquinated proteins are present in regions of the mutant brain that undergo degeneration. Co-localization of p62 and LAMP-2 in affected cells indicates that formation or recycling of the autolysosome is impaired. These results establish a role for PI(3,5)P<SUB>2</SUB> in autophagy in the mammalian central nervous system (CNS) and demonstrate that mutations affecting PI(3,5)P<SUB>2</SUB> can contribute to inclusion body disease.</p>
]]></description>
<dc:creator><![CDATA[Ferguson, C. J., Lenk, G. M., Meisler, M. H.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp460</dc:identifier>
<dc:title><![CDATA[Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4878</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4868</prism:startingPage>
<prism:section>ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4879?rss=1">
<title><![CDATA[FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4879?rss=1</link>
<description><![CDATA[
<p>Nonsyndromic orofacial clefts are a common complex birth defect caused by genetic and environmental factors and/or their interactions. A previous genome-wide linkage scan discovered a novel locus for cleft lip with or without cleft palate (CL/P) at 9q22&ndash;q33. To identify the etiologic gene, we undertook an iterative and complementary fine mapping strategy using family-based CL/P samples from Colombia, USA and the Philippines. Candidate genes within 9q22&ndash;q33 were sequenced, revealing 32 new variants. Concurrently, 397 SNPs spanning the 9q22&ndash;q33 2-LOD-unit interval were tested for association. Significant SNP and haplotype association signals (<I>P</I> = 1.45E &ndash; 08) narrowed the interval to a 200 kb region containing: <I>FOXE1, C9ORF156</I> and <I>HEMGN</I>. Association results were replicated in CL/P families of European descent and when all populations were combined the two most associated SNPs, rs3758249 (<I>P</I> = 5.01E &ndash; 13) and rs4460498 (<I>P</I> = 6.51E &ndash; 12), were located inside a 70 kb high linkage disequilibrium block containing <I>FOXE1</I>. Association signals for Caucasians and Asians clustered 5' and 3' of <I>FOXE1</I>, respectively. Isolated cleft palate (CP) was also associated, indicating that FOXE1 plays a role in two phenotypes thought to be genetically distinct. <I>Foxe1</I> expression was found in the epithelium undergoing fusion between the medial nasal and maxillary processes. Mutation screens of <I>FOXE1</I> identified two family-specific missense mutations at highly conserved amino acids. These data indicate that <I>FOXE1</I> is a major gene for CL/P and provides new insights for improved counseling and genetic interaction studies.</p>
]]></description>
<dc:creator><![CDATA[Moreno, L. M., Mansilla, M. A., Bullard, S. A., Cooper, M. E., Busch, T. D., Machida, J., Johnson, M. K., Brauer, D., Krahn, K., Daack-Hirsch, S., L'Heureux, J., Valencia-Ramirez, C., Rivera, D., Lopez, A. M., Moreno, M. A., Hing, A., Lammer, E. J., Jones, M., Christensen, K., Lie, R. T., Jugessur, A., Wilcox, A. J., Chines, P., Pugh, E., Doheny, K., Arcos-Burgos, M., Marazita, M. L., Murray, J. C., Lidral, A. C.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp444</dc:identifier>
<dc:title><![CDATA[FOXE1 association with both isolated cleft lip with or without cleft palate, and isolated cleft palate]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4896</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4879</prism:startingPage>
<prism:section>ASSOCIATION STUDIES ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4897?rss=1">
<title><![CDATA[Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4897?rss=1</link>
<description><![CDATA[
<p>FOXO1A and <I>FOXO3A</I> are two members of the <I>FoxO</I> family. <I>FOXO3A</I> has recently been linked to human longevity in Japanese, German and Italian populations. Here we tested the genetic contribution of <I>FOXO1A</I> and <I>FOXO3A</I> to the longevity phenotype in Han Chinese population. Six tagging SNPs from <I>FOXO1A</I> and <I>FOXO3A</I> were selected and genotyped in 1817 centenarians and younger individuals. Two SNPs of <I>FOXO1A</I> were found to be associated with longevity in women (<I>P</I> = 0.01&ndash;0.005), whereas all three SNPs of <I>FOXO3A</I> were associated with longevity in both genders (<I>P</I> = 0.005&ndash;0.001). One SNP from <I>FOXO1A</I> was found not to be associated with longevity. In haplotype association tests, the OR (95% CI) for haplotypes TTG and CCG of <I>FOXO1A</I> in association with female longevity were 0.72 (0.58&ndash;0.90) and 1.38 (1.08&ndash;1.76), <I>P</I> = 0.0033 and 0.0063, respectively. The haplotypes of <I>FOXO3A</I> were associated with longevity in men [GTC: OR (95% CI) = 0.67 (0.51&ndash;0.86), <I>P</I> = 0.0014; CGT: OR (95% CI) = 1.48 (1.12&ndash;1.94), <I>P</I> = 0.0035] and in women [GTC: OR (95% CI) = 0.75 (0.60&ndash;0.94), <I>P</I> = 0.0094; CGT: OR (95% CI) = 1.47 (1.16&ndash;1.86), <I>P</I> = 0.0009]. The haplotype association tests were validated by permutation analysis. The association of <I>FOXO1A</I> with female longevity was replicated in 700 centenarians and younger individuals that were sampled geographically different from the original population. Thus, we demonstrate that, unlike <I>FOXO3A, FOXO1A</I> is more closely associated with human female longevity, suggesting that the genetic contribution to longevity trait may be affected by genders.</p>
]]></description>
<dc:creator><![CDATA[Li, Y., Wang, W.-J., Cao, H., Lu, J., Wu, C., Hu, F.-Y., Guo, J., Zhao, L., Yang, F., Zhang, Y.-X., Li, W., Zheng, G.-Y., Cui, H., Chen, X., Zhu, Z., He, H., Dong, B., Mo, X., Zeng, Y., Tian, X.-L.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp459</dc:identifier>
<dc:title><![CDATA[Genetic association of FOXO1A and FOXO3A with longevity trait in Han Chinese populations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4904</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4897</prism:startingPage>
<prism:section>ASSOCIATION STUDIES ARTICLES</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4905?rss=1">
<title><![CDATA[Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4905?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Ashley, N., O'Rourke, A., Smith, C., Adams, S., Gowda, V., Zeviani, M., Brown, G. K., Fratter, C., Poulton, J.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp458</dc:identifier>
<dc:title><![CDATA[Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4906</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4905</prism:startingPage>
<prism:section>CORRIGENDA</prism:section>
</item>

<item rdf:about="http://hmg.oxfordjournals.org/cgi/content/short/18/24/4907?rss=1">
<title><![CDATA[NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation]]></title>
<link>http://hmg.oxfordjournals.org/cgi/content/short/18/24/4907?rss=1</link>
<description><![CDATA[]]></description>
<dc:creator><![CDATA[Deveault, C., Qian, J. H., Chebaro, W., Ao, A., Gilbert, L., Mehio, A., Khan, R., Tan, S. L., Wischmeijer, A., Coullin, P., Xie, X., Slim, R.]]></dc:creator>
<dc:date>Tue, 17 Nov 2009 06:54:15 PST</dc:date>
<dc:identifier>info:doi/10.1093/hmg/ddp461</dc:identifier>
<dc:title><![CDATA[NLRP7 mutations in women with diploid androgenetic and triploid moles: a proposed mechanism for mole formation]]></dc:title>
<dc:publisher>Oxford University Press</dc:publisher>
<prism:number>24</prism:number>
<prism:volume>18</prism:volume>
<prism:endingPage>4907</prism:endingPage>
<prism:publicationDate>2009-12-15</prism:publicationDate>
<prism:startingPage>4907</prism:startingPage>
<prism:section>CORRIGENDA</prism:section>
</item>

</rdf:RDF>